Brandon Probst completed his PhD in molecular and cell biology from the University Of Texas Southwestern Medical Center. Professionally, he has over 15 years of preclinical small molecule drug discovery experience in multiple therapeutic areas including the last 7 years working on rare disease indications. Dr. Probst is currently a Director of Disease Biology at Recursion Pharmaceuticals Inc. and has spent several years working on a project aimed at identifying novel therapeutics for HHT. He has a strong desire to find and develop game changing medicines for patients. Brandon lives in Lehi, UT wife his wife, Stephanie and their five children.